MICIT

Pharmaceutical preparations for the treatment of cancer, in particular based on nucleic acids and/or proteins; Medicines individually tailored for the respective patient, in particular based on nucleic acids and/or proteins

Scientific apparatus and instruments; Software algorithms being software programs, in particular for detecting and registering mutations in cancer patients

High-throughput analysis devices, in particular devices for next-generation sequencing for medical questions, as well as for gene expression profiling and for the detection of epigenetic changes

Research and development in the field of cancer immunotherapy, in particular research and development in the field of human and veterinary medical diagnostics and therapy using molecular biological, genetic engineering, biotechnological and/or bioinformatic methods, in particular using next-generation sequencing; Diagnostics of tumor markers for personalized therapy being scientific laboratory services or within the framework of scientific research for medical purposes

Medical, veterinary and pharmaceutical consultancy, in particular with regard to the selection of suitable therapies for all types of cancer; Conducting analyzes and treatments within the framework of personalized cancer immunotherapy; providing nucleic acid based therapies and/or checkpoint inhibitors